We are live on ! Find out more
ALGS icon

Aligos Therapeutics
ALGS

57 hedge funds and large institutions have $550M invested in Aligos Therapeutics in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 11

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

10% more funds holding

Funds holding: 52 → 57 (+5)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% less ownership

Funds ownership: 2.83% → 2.83% (-0%)

10% less capital invested

Capital invested by funds: $612M → $550M (-$62.1M)

Holders
57
Holders Change
+5
Holders Change %
+9.62%
% of All Funds
0.99%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
21
Reduced
11
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$9.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$9.4M
3
ACP
Acuta Capital Partners
California
+$5.46M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$4.49M
5
State Street
State Street
Massachusetts
+$3.22M

Top Sellers

Rank Fund Capital Flow
1
VVM
Versant Venture Management
California
-$24.8M
2
CAM
Cormorant Asset Management
Massachusetts
-$9.22M
3
LGM
Logos Global Management
California
-$6.73M
4
Millennium Management
Millennium Management
New York
-$741K
5
SI
Sofinnova Investments
California
-$548K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
$26K +$16.6K +26 +104%
UBS Group
52
UBS Group
Switzerland
$7K -$83.5K -131 -90%
EWA
53
Evolution Wealth Advisors
Florida
$6K – – –
SOW
54
State of Wyoming
Wyoming
$3K +$1.27K +2 +67%
NFSG
55
Newbridge Financial Services Group
Florida
$1K – – –
AIG
56
American International Group
New York
$214 +$113K +177 +73%
Millennium Management
57
Millennium Management
New York
– -$741K -1,303 Closed
California Public Employees Retirement System
58
California Public Employees Retirement System
California
– -$453K -797 Closed
MS
59
Maven Securities
Jersey
– -$364K -729 Closed
Alyeska Investment Group
60
Alyeska Investment Group
Illinois
– -$341K -600 Closed
GTCM
61
Gyon Technologies Capital Management
New Jersey
– -$248K -436 Closed
Susquehanna International Group
62
Susquehanna International Group
Pennsylvania
– -$209K -367 Closed
Wells Fargo
63
Wells Fargo
California
– -$74K -131 Closed
Bank of Montreal
64
Bank of Montreal
Ontario, Canada
– -$7K -13 Closed
PAM
65
Panagora Asset Management
Massachusetts
– -$1K -1 Closed
US Bancorp
66
US Bancorp
Minnesota
– +$637 +1 New
1 2
3

ALGS Hedge Fund Activity: Q2 2021 in Review

57 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Aligos Therapeutics (ALGS) for Q2 2021, worth a combined $550M — down 10% from $612M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ALGS positions and 9 closed out — a net gain of 5 holders — while 21 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock, adding an estimated $9.9M. The largest seller was Versant Venture Management, cutting an estimated $24.8M.

  • 57 institutional investors held Aligos Therapeutics (ALGS) as of Q2 2021, up from 52 in Q1 2021.
  • Funds reported $550M of Aligos Therapeutics stock for Q2 2021, down 10% quarter-over-quarter.
  • 14 funds opened new Aligos Therapeutics positions in Q2 2021 and 9 closed out, a net change of +5 holders.
  • The largest Aligos Therapeutics buyer in Q2 2021 was BlackRock, an estimated $9.9M added.
  • The largest Aligos Therapeutics seller in Q2 2021 was Versant Venture Management, an estimated $24.8M sold.

Based on aggregated 13F filings for Q2 2021.